Industry News
Pharmaceutical Industry News
Democrats’ Long-Sought Plan for Lowering Drug Costs Is at Hand
Empowering Medicare to negotiate prices directly with drug makers has been a Democratic goal for 30 years, one the pharmaceutical industry has fought ferociously.
U.S. Could Have Had Many More Doses of Monkeypox Vaccine This Year
The Department of Health and Human Services delayed asking the manufacturer to process the bulk vaccine the government already owned into vials.
Analysis Deems Biden’s Climate and Tax Bill Fiscally Responsible
Despite Republican claims, the new legislation would be only a modest corporate tax increase, Congress’s Joint Committee on Taxation found.
Maybe Joe Biden Knows Joe Manchin Better Than We Thought
There is at least one person in politics who was not taken by surprise by the new climate and tax package.
Biden Savors Much-Needed Victories. But Will the Highs Overshadow the Lows?
With the midterm elections around the corner, the challenge for President Biden is to make sure his latest successes resonate with Americans who remain deeply skeptical about the future.
Allergan Reaches Tentative $2.37 Billion Deal to Settle Opioid Suits
If finalized, the agreement, along with a companion deal reached by Teva earlier this week, would send as much as $6.6 billion to communities harmed by the opioid epidemic.
Biden Administration Plans to Offer Updated Booster Shots in September
With reformulated shots from Pfizer and Moderna on the horizon, the F.D.A. has decided that Americans under 50 should wait to receive second boosters.
Democrats’ Plan to Fight Inflation May Lower Costs Over Time
A package of tax increases, lower drug prices and other provisions aimed at reducing the federal budget deficit could alleviate rapid price gains.
Manchin, in Reversal, Agrees to Quick Action on Climate and Tax Plan
The West Virginia Democrat, a holdout on his party’s domestic agenda, said the package would reduce inflation, a concern he had cited in rejecting it just weeks ago.
Cómo vivir con la COVID-19 cuando estás harto de la pandemia
El aumento de la subvariante BA.5 es un recordatorio de que debemos tomar precauciones para evitar enfermarnos, desacelerar el ciclo implacable de nuevas variantes y minimizar la interrupción de nuestra vida diaria.
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids
The deal would end thousands of lawsuits against one of the largest producers of opioid painkillers during the height of the opioid epidemic.
Fentanyl From the Government? A Vancouver Experiment Aims to Stop Overdoses
A city on the forefront of harm reduction has taken the concept to a new level in an effort to address the growing toxicity of street drugs.
Omicron BA.5 Surge: 5 Ways to Stay Safe
The BA.5 surge is a reminder that we need to take precautions to avoid illness, slow the relentless cycle of new variants and minimize the disruption to our daily lives.
The New Abortion Battleground
The political fight over abortion will increasingly be a battle over the mailing of pills into Republican-run states.
After Roe, Pregnant Women With Cancer Diagnoses May Face Wrenching Choices
Urgent questions arise about how care of pregnant women with cancer will change in states where women are unable to terminate pregnancies
¿Cuándo caducan realmente los medicamentos vencidos?
Muchos tenemos medicamentos que ya pasaron su fecha de vencimiento, pero ¿todavía es seguro usarlos?
F.D.A. Seeks Outside Review of Troubled Food and Tobacco Units
The agency’s commissioner asked an external foundation to examine its operations in the wake of the baby formula and vaping crises.
Can a ‘Magic’ Protein Slow the Aging Process?
Elevian is one of several companies searching for ways to increase life span — in this case, using a protein called GDF11. But challenges lie ahead.
Sky-High Prices Are Only Part of the Problem
Inflation has unmasked the depths of our affordability crisis.
Why Build Back Better Is a Health Care Bill Now
Only two provisions in a once-sprawling social spending package have survived; they would lower prescription drug prices in Medicare and insurance premiums for millions of Americans.